Toll Free: 1-888-928-9744
Published: Nov, 2016 | Pages:
163 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ankylosing Spondylitis - Pipeline Review, H2 2016, provides an overview of the Ankylosing Spondylitis (Musculoskeletal Disorders) pipeline landscape. Ankylosing spondylitis is a type of arthritis that affects the spine. Ankylosing spondylitis symptoms include pain and stiffness from the neck down to the lower back. The spine's bones (vertebrae) may grow or fuse together, resulting in a rigid spine. These changes may be mild or severe, and may lead to a stooped-over posture. Report Highlights Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Ankylosing Spondylitis - Pipeline Review, H2 2016, provides comprehensive information on the therapeutics under development for Ankylosing Spondylitis (Musculoskeletal Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. The Ankylosing Spondylitis (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Ankylosing Spondylitis (Bekhterev's Disease) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 6, 7, 2, 7, 2, 13, 6 and 2 respectively.Ankylosing Spondylitis. Ankylosing Spondylitis (Musculoskeletal Disorders) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis. Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data. Scope - The pipeline guide provides a snapshot of the global therapeutic landscape of Ankylosing Spondylitis (Musculoskeletal Disorders). - The pipeline guide reviews pipeline therapeutics for Ankylosing Spondylitis (Musculoskeletal Disorders) by companies and universities/research institutes based on information derived from company and industry-specific sources. - The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages. - The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities. - The pipeline guide reviews key companies involved in Ankylosing Spondylitis (Musculoskeletal Disorders) therapeutics and enlists all their major and minor projects. - The pipeline guide evaluates Ankylosing Spondylitis (Musculoskeletal Disorders) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. - The pipeline guide encapsulates all the dormant and discontinued pipeline projects. - The pipeline guide reviews latest news related to pipeline therapeutics for Ankylosing Spondylitis (Musculoskeletal Disorders) Reasons To Buy - Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies. - Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage. - Find and recognize significant and varied types of therapeutics under development for Ankylosing Spondylitis (Musculoskeletal Disorders). - Classify potential new clients or partners in the target demographic. - Develop tactical initiatives by understanding the focus areas of leading companies. - Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics. - Formulate corrective measures for pipeline projects by understanding Ankylosing Spondylitis (Musculoskeletal Disorders) pipeline depth and focus of Indication therapeutics. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope. - Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Table of Contents Table of Contents 2 List of Tables 5 List of Figures 6 Introduction 7 Global Markets Direct Report Coverage 7 Ankylosing Spondylitis (Bekhterev's Disease) Overview 8 Therapeutics Development 9 Pipeline Products for Ankylosing Spondylitis (Bekhterev's Disease) - Overview 9 Ankylosing Spondylitis (Bekhterev's Disease) - Therapeutics under Development by Companies 10 Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Products Glance 12 Late Stage Products 12 Clinical Stage Products 13 Early Stage Products 14 Unknown Stage Products 15 Ankylosing Spondylitis (Bekhterev's Disease) - Products under Development by Companies 16 Ankylosing Spondylitis (Bekhterev's Disease) - Companies Involved in Therapeutics Development 19 AbbVie Inc 19 Alteogen Inc. 20 Amgen Inc. 21 BIOCAD 22 Biocon Limited 23 Bionovis SA 24 Brickell Biotech, Inc. 25 Celgene Corporation 26 Coherus BioSciences, Inc. 27 Genor BioPharma Co Ltd 28 Innovent Biologics, Inc. 29 Johnson & Johnson 30 Momenta Pharmaceuticals, Inc. 31 Mycenax Biotech Inc. 32 NeuClone Pty Ltd 33 Novartis AG 34 Oncobiologics, Inc. 35 Panacea Biotec Limited 36 Protalix BioTherapeutics, Inc. 37 Reliance Life Sciences Pvt. Ltd. 38 Sandoz International GmbH 39 Shanghai Pharmaceutical Co., Ltd. 40 Therapeutic Proteins International, LLC 41 Vitae Pharmaceuticals, Inc. 42 Xbrane Biopharma AB 43 Ankylosing Spondylitis (Bekhterev's Disease) - Therapeutics Assessment 44 Assessment by Monotherapy Products 44 Assessment by Target 45 Assessment by Mechanism of Action 47 Assessment by Route of Administration 49 Assessment by Molecule Type 51 Drug Profiles 53 adalimumab biosimilar - Drug Profile 53 adalimumab biosimilar - Drug Profile 55 adalimumab biosimilar - Drug Profile 56 adalimumab biosimilar - Drug Profile 57 adalimumab biosimilar - Drug Profile 58 adalimumab biosimilar - Drug Profile 59 adalimumab biosimilar - Drug Profile 60 adalimumab biosimilar - Drug Profile 62 adalimumab biosimilar - Drug Profile 64 adalimumab biosimilar - Drug Profile 65 adalimumab biosimilar - Drug Profile 66 adalimumab biosimilar - Drug Profile 67 adalimumab biosimilar - Drug Profile 68 adalimumab biosimilar - Drug Profile 69 apremilast - Drug Profile 70 BBI-6000 - Drug Profile 81 certolizumab pegol biosimilar - Drug Profile 83 DNX-114 - Drug Profile 84 DNX-514 - Drug Profile 85 etanercept biosimilar - Drug Profile 86 etanercept biosimilar - Drug Profile 87 etanercept biosimilar - Drug Profile 89 etanercept biosimilar - Drug Profile 90 etanercept biosimilar - Drug Profile 91 etanercept biosimilar - Drug Profile 92 etanercept biosimilar - Drug Profile 93 etanercept biosimilar - Drug Profile 96 etanercept biosimilar - Drug Profile 97 golimumab - Drug Profile 99 golimumab biosimilar - Drug Profile 107 golimumab biosimilar - Drug Profile 108 infliximab biosimilar - Drug Profile 109 infliximab biosimilar - Drug Profile 110 infliximab biosimilar - Drug Profile 111 infliximab biosimilar - Drug Profile 114 infliximab biosimilar - Drug Profile 115 infliximab biosimilar - Drug Profile 118 infliximab biosimilar - Drug Profile 119 infliximab biosimilar - Drug Profile 120 INV-17 - Drug Profile 121 risankizumab - Drug Profile 122 secukinumab - Drug Profile 125 thalidomide - Drug Profile 138 upadacitinib tartrate - Drug Profile 139 VTP-43742 - Drug Profile 141 Ankylosing Spondylitis (Bekhterev's Disease) - Dormant Projects 143 Ankylosing Spondylitis (Bekhterev's Disease) - Discontinued Products 145 Ankylosing Spondylitis (Bekhterev's Disease) - Product Development Milestones 146 Featured News & Press Releases 146 Appendix 159 Methodology 159 Coverage 159 Secondary Research 159 Primary Research 159 Expert Panel Validation 159 Contact Us 159 Disclaimer 160
List of Tables Number of Products under Development for Ankylosing Spondylitis (Bekhterev's Disease), H2 2016 12 Number of Products under Development by Companies, H2 2016 13 Number of Products under Development by Companies, H2 2016 (Contd..1) 14 Comparative Analysis by Late Stage Development, H2 2016 15 Comparative Analysis by Clinical Stage Development, H2 2016 16 Comparative Analysis by Early Stage Development, H2 2016 17 Comparative Analysis by Unknown Stage Development, H2 2016 18 Products under Development by Companies, H2 2016 19 Products under Development by Companies, H2 2016 (Contd..1) 20 Products under Development by Companies, H2 2016 (Contd..2) 21 Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by AbbVie Inc, H2 2016 22 Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Alteogen Inc., H2 2016 23 Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Amgen Inc., H2 2016 24 Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by BIOCAD, H2 2016 25 Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Biocon Limited, H2 2016 26 Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Bionovis SA, H2 2016 27 Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Brickell Biotech, Inc., H2 2016 28 Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Celgene Corporation, H2 2016 29 Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Coherus BioSciences, Inc., H2 2016 30 Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Genor BioPharma Co Ltd, H2 2016 31 Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Innovent Biologics, Inc., H2 2016 32 Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Johnson & Johnson, H2 2016 33 Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Momenta Pharmaceuticals, Inc., H2 2016 34 Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Mycenax Biotech Inc., H2 2016 35 Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by NeuClone Pty Ltd, H2 2016 36 Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Novartis AG, H2 2016 37 Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Oncobiologics, Inc., H2 2016 38 Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Panacea Biotec Limited, H2 2016 39 Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Protalix BioTherapeutics, Inc., H2 2016 40 Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Reliance Life Sciences Pvt. Ltd., H2 2016 41 Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Sandoz International GmbH, H2 2016 42 Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Shanghai Pharmaceutical Co., Ltd., H2 2016 43 Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Therapeutic Proteins International, LLC, H2 2016 44 Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Vitae Pharmaceuticals, Inc., H2 2016 45 Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Xbrane Biopharma AB, H2 2016 46 Assessment by Monotherapy Products, H2 2016 47 Number of Products by Stage and Target, H2 2016 49 Number of Products by Stage and Mechanism of Action, H2 2016 51 Number of Products by Stage and Route of Administration, H2 2016 53 Number of Products by Stage and Molecule Type, H2 2016 55 Ankylosing Spondylitis (Bekhterev's Disease) - Dormant Projects, H2 2016 146 Ankylosing Spondylitis (Bekhterev's Disease) - Dormant Projects (Contd..1), H2 2016 147 Ankylosing Spondylitis (Bekhterev's Disease) - Discontinued Products, H2 2016 148
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.